Drug Type Small molecule drug |
Synonyms VZMC013 |
Target |
Mechanism CCR5 modulators(C-C chemokine receptor type 5 modulators), μ opioid receptor modulators(Mu opioid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | US | 24 May 2021 |